nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethoprim—ABCB1—hematologic cancer	0.116	1	CbGaD
Trimethoprim—TYMS—Gemcitabine—hematologic cancer	0.0727	0.131	CbGbCtD
Trimethoprim—DHFR—Methotrexate—hematologic cancer	0.0492	0.0886	CbGbCtD
Trimethoprim—TYMS—Methotrexate—hematologic cancer	0.0343	0.0617	CbGbCtD
Trimethoprim—CYP2C9—Bexarotene—hematologic cancer	0.0183	0.0329	CbGbCtD
Trimethoprim—ABCB1—Lenalidomide—hematologic cancer	0.0177	0.0319	CbGbCtD
Trimethoprim—CYP2C8—Bortezomib—hematologic cancer	0.0161	0.0289	CbGbCtD
Trimethoprim—CYP2C9—Idarubicin—hematologic cancer	0.0152	0.0273	CbGbCtD
Trimethoprim—CYP2C8—Ifosfamide—hematologic cancer	0.0123	0.0222	CbGbCtD
Trimethoprim—CYP2C9—Bortezomib—hematologic cancer	0.0112	0.0202	CbGbCtD
Trimethoprim—CYP2C8—Nilotinib—hematologic cancer	0.0107	0.0192	CbGbCtD
Trimethoprim—CYP3A4—Bexarotene—hematologic cancer	0.0106	0.0191	CbGbCtD
Trimethoprim—ABCB1—Daunorubicin—hematologic cancer	0.0104	0.0187	CbGbCtD
Trimethoprim—ABCB1—Alitretinoin—hematologic cancer	0.0102	0.0183	CbGbCtD
Trimethoprim—CYP3A4—Busulfan—hematologic cancer	0.00989	0.0178	CbGbCtD
Trimethoprim—CYP3A4—Lomustine—hematologic cancer	0.00989	0.0178	CbGbCtD
Trimethoprim—CYP2C9—Thalidomide—hematologic cancer	0.00977	0.0176	CbGbCtD
Trimethoprim—CYP2C9—Teniposide—hematologic cancer	0.00932	0.0168	CbGbCtD
Trimethoprim—CYP3A4—Thiotepa—hematologic cancer	0.00881	0.0158	CbGbCtD
Trimethoprim—CYP2C9—Ifosfamide—hematologic cancer	0.0086	0.0155	CbGbCtD
Trimethoprim—CYP2C9—Imatinib—hematologic cancer	0.00821	0.0148	CbGbCtD
Trimethoprim—ABCB1—Imatinib—hematologic cancer	0.00797	0.0143	CbGbCtD
Trimethoprim—CYP2C9—Nilotinib—hematologic cancer	0.00746	0.0134	CbGbCtD
Trimethoprim—ABCB1—Nilotinib—hematologic cancer	0.00724	0.013	CbGbCtD
Trimethoprim—ABCB1—Vinorelbine—hematologic cancer	0.00718	0.0129	CbGbCtD
Trimethoprim—CYP3A4—Methoxsalen—hematologic cancer	0.00685	0.0123	CbGbCtD
Trimethoprim—CYP3A4—Bortezomib—hematologic cancer	0.00652	0.0117	CbGbCtD
Trimethoprim—ABCB1—Dasatinib—hematologic cancer	0.0064	0.0115	CbGbCtD
Trimethoprim—ABCB1—Mitoxantrone—hematologic cancer	0.00632	0.0114	CbGbCtD
Trimethoprim—CYP3A4—Daunorubicin—hematologic cancer	0.00623	0.0112	CbGbCtD
Trimethoprim—CYP2C8—Etoposide—hematologic cancer	0.00589	0.0106	CbGbCtD
Trimethoprim—ABCB1—Betamethasone—hematologic cancer	0.00564	0.0101	CbGbCtD
Trimethoprim—ABCB1—Gemcitabine—hematologic cancer	0.00559	0.01	CbGbCtD
Trimethoprim—ABCB1—Prednisolone—hematologic cancer	0.00556	0.01	CbGbCtD
Trimethoprim—CYP3A4—Cytarabine—hematologic cancer	0.0055	0.00989	CbGbCtD
Trimethoprim—CYP3A4—Teniposide—hematologic cancer	0.00542	0.00974	CbGbCtD
Trimethoprim—ABCB1—Prednisone—hematologic cancer	0.00525	0.00944	CbGbCtD
Trimethoprim—CYP3A4—Ifosfamide—hematologic cancer	0.005	0.00899	CbGbCtD
Trimethoprim—ABCB1—Irinotecan—hematologic cancer	0.00498	0.00895	CbGbCtD
Trimethoprim—CYP2C8—Dexamethasone—hematologic cancer	0.00484	0.00871	CbGbCtD
Trimethoprim—CYP3A4—Imatinib—hematologic cancer	0.00478	0.00859	CbGbCtD
Trimethoprim—CYP3A4—Ruxolitinib—hematologic cancer	0.0045	0.00809	CbGbCtD
Trimethoprim—ABCB1—Vinblastine—hematologic cancer	0.00443	0.00796	CbGbCtD
Trimethoprim—ABCB1—Vincristine—hematologic cancer	0.00435	0.00783	CbGbCtD
Trimethoprim—CYP3A4—Nilotinib—hematologic cancer	0.00434	0.0078	CbGbCtD
Trimethoprim—CYP3A4—Vinorelbine—hematologic cancer	0.0043	0.00774	CbGbCtD
Trimethoprim—CYP2C9—Cisplatin—hematologic cancer	0.00418	0.00752	CbGbCtD
Trimethoprim—ABCB1—Cisplatin—hematologic cancer	0.00406	0.0073	CbGbCtD
Trimethoprim—ABCB1—Etoposide—hematologic cancer	0.00399	0.00717	CbGbCtD
Trimethoprim—CYP3A4—Triamcinolone—hematologic cancer	0.00394	0.00708	CbGbCtD
Trimethoprim—CYP3A4—Dasatinib—hematologic cancer	0.00384	0.0069	CbGbCtD
Trimethoprim—CYP3A4—Mitoxantrone—hematologic cancer	0.00379	0.00681	CbGbCtD
Trimethoprim—CYP2C9—Dexamethasone—hematologic cancer	0.00338	0.00608	CbGbCtD
Trimethoprim—CYP3A4—Betamethasone—hematologic cancer	0.00338	0.00607	CbGbCtD
Trimethoprim—CYP3A4—Prednisolone—hematologic cancer	0.00333	0.00599	CbGbCtD
Trimethoprim—ABCB1—Dexamethasone—hematologic cancer	0.00328	0.0059	CbGbCtD
Trimethoprim—CYP3A4—Prednisone—hematologic cancer	0.00315	0.00566	CbGbCtD
Trimethoprim—CYP3A4—Irinotecan—hematologic cancer	0.00298	0.00536	CbGbCtD
Trimethoprim—ABCB1—Doxorubicin—hematologic cancer	0.00272	0.00489	CbGbCtD
Trimethoprim—CYP3A4—Vinblastine—hematologic cancer	0.00265	0.00477	CbGbCtD
Trimethoprim—ABCB1—Methotrexate—hematologic cancer	0.00263	0.00474	CbGbCtD
Trimethoprim—CYP3A4—Vincristine—hematologic cancer	0.00261	0.00469	CbGbCtD
Trimethoprim—CYP3A4—Etoposide—hematologic cancer	0.00239	0.0043	CbGbCtD
Trimethoprim—CYP3A4—Dexamethasone—hematologic cancer	0.00196	0.00353	CbGbCtD
Trimethoprim—TYMS—hematopoietic system—hematologic cancer	0.00184	0.0795	CbGeAlD
Trimethoprim—DHFR—hematopoietic system—hematologic cancer	0.00182	0.0787	CbGeAlD
Trimethoprim—CYP3A4—Doxorubicin—hematologic cancer	0.00163	0.00293	CbGbCtD
Trimethoprim—Papaverine—PDE4B—hematologic cancer	0.00156	1	CrCbGaD
Trimethoprim—TYMS—gonad—hematologic cancer	0.0014	0.0604	CbGeAlD
Trimethoprim—DHFR—gonad—hematologic cancer	0.00139	0.0598	CbGeAlD
Trimethoprim—TYMS—blood—hematologic cancer	0.00122	0.0527	CbGeAlD
Trimethoprim—DHFR—blood—hematologic cancer	0.00121	0.0521	CbGeAlD
Trimethoprim—TYMS—bone marrow—hematologic cancer	0.00118	0.0509	CbGeAlD
Trimethoprim—DHFR—bone marrow—hematologic cancer	0.00117	0.0504	CbGeAlD
Trimethoprim—TYMS—lung—hematologic cancer	0.00107	0.0462	CbGeAlD
Trimethoprim—DHFR—lung—hematologic cancer	0.00106	0.0457	CbGeAlD
Trimethoprim—TYMS—testis—hematologic cancer	0.00101	0.0436	CbGeAlD
Trimethoprim—DHFR—testis—hematologic cancer	0.000999	0.0431	CbGeAlD
Trimethoprim—CYP2C8—hematopoietic system—hematologic cancer	0.000905	0.0391	CbGeAlD
Trimethoprim—CYP2C9—hematopoietic system—hematologic cancer	0.000804	0.0347	CbGeAlD
Trimethoprim—TYMS—lymph node—hematologic cancer	0.000731	0.0316	CbGeAlD
Trimethoprim—DHFR—lymph node—hematologic cancer	0.000724	0.0313	CbGeAlD
Trimethoprim—CYP3A4—hematopoietic system—hematologic cancer	0.000613	0.0265	CbGeAlD
Trimethoprim—CYP2C8—blood—hematologic cancer	0.000599	0.0259	CbGeAlD
Trimethoprim—TYMS—Nilotinib—Imatinib—hematologic cancer	0.000547	0.139	CbGdCrCtD
Trimethoprim—CYP2C9—blood—hematologic cancer	0.000532	0.023	CbGeAlD
Trimethoprim—CYP2C8—testis—hematologic cancer	0.000496	0.0214	CbGeAlD
Trimethoprim—ABCB1—hematopoietic system—hematologic cancer	0.000434	0.0187	CbGeAlD
Trimethoprim—CYP3A4—blood—hematologic cancer	0.000406	0.0175	CbGeAlD
Trimethoprim—TYMS—Vitamin A—Alitretinoin—hematologic cancer	0.00033	0.0837	CbGdCrCtD
Trimethoprim—ABCB1—gonad—hematologic cancer	0.00033	0.0142	CbGeAlD
Trimethoprim—ABCB1—blood—hematologic cancer	0.000287	0.0124	CbGeAlD
Trimethoprim—ABCB1—bone marrow—hematologic cancer	0.000278	0.012	CbGeAlD
Trimethoprim—ABCB1—lung—hematologic cancer	0.000252	0.0109	CbGeAlD
Trimethoprim—ABCB1—testis—hematologic cancer	0.000238	0.0103	CbGeAlD
Trimethoprim—TYMS—Tretinoin—Alitretinoin—hematologic cancer	0.000231	0.0585	CbGdCrCtD
Trimethoprim—TYMS—Isotretinoin—Alitretinoin—hematologic cancer	0.000231	0.0585	CbGdCrCtD
Trimethoprim—TYMS—Podofilox—Teniposide—hematologic cancer	0.00023	0.0583	CbGdCrCtD
Trimethoprim—TYMS—Menadione—Thalidomide—hematologic cancer	0.000174	0.0442	CbGdCrCtD
Trimethoprim—ABCB1—lymph node—hematologic cancer	0.000172	0.00744	CbGeAlD
Trimethoprim—TYMS—Vincristine—Vinorelbine—hematologic cancer	0.000146	0.0371	CbGdCrCtD
Trimethoprim—TYMS—Vinorelbine—Vinblastine—hematologic cancer	0.000137	0.0347	CbGdCrCtD
Trimethoprim—TYMS—Vinorelbine—Vincristine—hematologic cancer	0.000137	0.0347	CbGdCrCtD
Trimethoprim—TYMS—Podofilox—Etoposide—hematologic cancer	0.000137	0.0347	CbGdCrCtD
Trimethoprim—TYMS—Vinblastine—Vinorelbine—hematologic cancer	0.000118	0.0299	CbGdCrCtD
Trimethoprim—TYMS—Vincristine—Vinblastine—hematologic cancer	0.000117	0.0297	CbGdCrCtD
Trimethoprim—TYMS—Vinblastine—Vincristine—hematologic cancer	9.41e-05	0.0239	CbGdCrCtD
Trimethoprim—TYMS—Azacitidine—Pentostatin—hematologic cancer	8.92e-05	0.0226	CbGdCrCtD
Trimethoprim—TYMS—Azacitidine—Clofarabine—hematologic cancer	7.95e-05	0.0202	CbGdCrCtD
Trimethoprim—TYMS—Azacitidine—Nelarabine—hematologic cancer	7.48e-05	0.019	CbGdCrCtD
Trimethoprim—TYMS—Azacitidine—Fludarabine—hematologic cancer	5.84e-05	0.0148	CbGdCrCtD
Trimethoprim—TYMS—Azacitidine—Gemcitabine—hematologic cancer	5.51e-05	0.014	CbGdCrCtD
Trimethoprim—TYMS—Azacitidine—Cytarabine—hematologic cancer	5.51e-05	0.014	CbGdCrCtD
Trimethoprim—TYMS—Azacitidine—Cladribine—hematologic cancer	5.37e-05	0.0136	CbGdCrCtD
Trimethoprim—TYMS—Clobetasol propionate—Dexamethasone—hematologic cancer	3.39e-05	0.00861	CbGdCrCtD
Trimethoprim—TYMS—Clobetasol propionate—Betamethasone—hematologic cancer	3.39e-05	0.00861	CbGdCrCtD
Trimethoprim—TYMS—Flunisolide—Betamethasone—hematologic cancer	3.35e-05	0.0085	CbGdCrCtD
Trimethoprim—TYMS—Flunisolide—Dexamethasone—hematologic cancer	3.35e-05	0.0085	CbGdCrCtD
Trimethoprim—TYMS—Clobetasol propionate—Triamcinolone—hematologic cancer	3.32e-05	0.00842	CbGdCrCtD
Trimethoprim—TYMS—Triamcinolone—Betamethasone—hematologic cancer	3.32e-05	0.00841	CbGdCrCtD
Trimethoprim—TYMS—Triamcinolone—Dexamethasone—hematologic cancer	3.32e-05	0.00841	CbGdCrCtD
Trimethoprim—Vomiting—Irinotecan—hematologic cancer	3.29e-05	0.000152	CcSEcCtD
Trimethoprim—Vomiting—Mitoxantrone—hematologic cancer	3.29e-05	0.000152	CcSEcCtD
Trimethoprim—Immune system disorder—Methotrexate—hematologic cancer	3.28e-05	0.000152	CcSEcCtD
Trimethoprim—Nausea—Alitretinoin—hematologic cancer	3.27e-05	0.000152	CcSEcCtD
Trimethoprim—Convulsion—Prednisone—hematologic cancer	3.27e-05	0.000152	CcSEcCtD
Trimethoprim—TYMS—Flunisolide—Triamcinolone—hematologic cancer	3.27e-05	0.00831	CbGdCrCtD
Trimethoprim—Mediastinal disorder—Methotrexate—hematologic cancer	3.27e-05	0.000152	CcSEcCtD
Trimethoprim—Agranulocytosis—Doxorubicin—hematologic cancer	3.27e-05	0.000151	CcSEcCtD
Trimethoprim—Rash—Mitoxantrone—hematologic cancer	3.26e-05	0.000151	CcSEcCtD
Trimethoprim—Rash—Irinotecan—hematologic cancer	3.26e-05	0.000151	CcSEcCtD
Trimethoprim—Dermatitis—Irinotecan—hematologic cancer	3.26e-05	0.000151	CcSEcCtD
Trimethoprim—Dermatitis—Mitoxantrone—hematologic cancer	3.26e-05	0.000151	CcSEcCtD
Trimethoprim—Headache—Irinotecan—hematologic cancer	3.24e-05	0.00015	CcSEcCtD
Trimethoprim—Headache—Mitoxantrone—hematologic cancer	3.24e-05	0.00015	CcSEcCtD
Trimethoprim—Nausea—Ifosfamide—hematologic cancer	3.24e-05	0.00015	CcSEcCtD
Trimethoprim—TYMS—Fluticasone Propionate—Dexamethasone—hematologic cancer	3.23e-05	0.00821	CbGdCrCtD
Trimethoprim—TYMS—Fluticasone Propionate—Betamethasone—hematologic cancer	3.23e-05	0.00821	CbGdCrCtD
Trimethoprim—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	3.23e-05	0.00015	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Betamethasone—hematologic cancer	3.23e-05	0.00015	CcSEcCtD
Trimethoprim—Arthralgia—Prednisone—hematologic cancer	3.22e-05	0.000149	CcSEcCtD
Trimethoprim—Myalgia—Prednisone—hematologic cancer	3.22e-05	0.000149	CcSEcCtD
Trimethoprim—Feeling abnormal—Triamcinolone—hematologic cancer	3.22e-05	0.000149	CcSEcCtD
Trimethoprim—Diarrhoea—Cisplatin—hematologic cancer	3.21e-05	0.000149	CcSEcCtD
Trimethoprim—Erythema multiforme—Epirubicin—hematologic cancer	3.21e-05	0.000149	CcSEcCtD
Trimethoprim—Anxiety—Prednisone—hematologic cancer	3.21e-05	0.000149	CcSEcCtD
Trimethoprim—Vomiting—Gemcitabine—hematologic cancer	3.2e-05	0.000148	CcSEcCtD
Trimethoprim—Insomnia—Betamethasone—hematologic cancer	3.2e-05	0.000148	CcSEcCtD
Trimethoprim—Insomnia—Dexamethasone—hematologic cancer	3.2e-05	0.000148	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	3.2e-05	0.000148	CcSEcCtD
Trimethoprim—Mental disorder—Methotrexate—hematologic cancer	3.18e-05	0.000147	CcSEcCtD
Trimethoprim—Rash—Gemcitabine—hematologic cancer	3.18e-05	0.000147	CcSEcCtD
Trimethoprim—Dermatitis—Gemcitabine—hematologic cancer	3.17e-05	0.000147	CcSEcCtD
Trimethoprim—Eye disorder—Epirubicin—hematologic cancer	3.17e-05	0.000147	CcSEcCtD
Trimethoprim—Hypersensitivity—Etoposide—hematologic cancer	3.17e-05	0.000147	CcSEcCtD
Trimethoprim—Tinnitus—Epirubicin—hematologic cancer	3.17e-05	0.000147	CcSEcCtD
Trimethoprim—TYMS—Fluticasone Propionate—Triamcinolone—hematologic cancer	3.16e-05	0.00802	CbGdCrCtD
Trimethoprim—Malnutrition—Methotrexate—hematologic cancer	3.16e-05	0.000146	CcSEcCtD
Trimethoprim—Erythema—Methotrexate—hematologic cancer	3.16e-05	0.000146	CcSEcCtD
Trimethoprim—Headache—Gemcitabine—hematologic cancer	3.16e-05	0.000146	CcSEcCtD
Trimethoprim—Nausea—Vincristine—hematologic cancer	3.16e-05	0.000146	CcSEcCtD
Trimethoprim—TYMS—Clobetasol propionate—Prednisone—hematologic cancer	3.15e-05	0.00799	CbGdCrCtD
Trimethoprim—Hypersensitivity—Prednisolone—hematologic cancer	3.13e-05	0.000145	CcSEcCtD
Trimethoprim—Dyspepsia—Dexamethasone—hematologic cancer	3.12e-05	0.000144	CcSEcCtD
Trimethoprim—Dyspepsia—Betamethasone—hematologic cancer	3.12e-05	0.000144	CcSEcCtD
Trimethoprim—TYMS—Flunisolide—Prednisone—hematologic cancer	3.11e-05	0.00788	CbGdCrCtD
Trimethoprim—Urinary tract disorder—Doxorubicin—hematologic cancer	3.1e-05	0.000144	CcSEcCtD
Trimethoprim—Urticaria—Triamcinolone—hematologic cancer	3.1e-05	0.000144	CcSEcCtD
Trimethoprim—Connective tissue disorder—Doxorubicin—hematologic cancer	3.09e-05	0.000143	CcSEcCtD
Trimethoprim—Body temperature increased—Triamcinolone—hematologic cancer	3.09e-05	0.000143	CcSEcCtD
Trimethoprim—Anaphylactic shock—Prednisone—hematologic cancer	3.08e-05	0.000143	CcSEcCtD
Trimethoprim—Urethral disorder—Doxorubicin—hematologic cancer	3.08e-05	0.000143	CcSEcCtD
Trimethoprim—Decreased appetite—Dexamethasone—hematologic cancer	3.08e-05	0.000143	CcSEcCtD
Trimethoprim—Decreased appetite—Betamethasone—hematologic cancer	3.08e-05	0.000143	CcSEcCtD
Trimethoprim—TYMS—Triamcinolone—Prednisone—hematologic cancer	3.07e-05	0.0078	CbGdCrCtD
Trimethoprim—Nausea—Irinotecan—hematologic cancer	3.07e-05	0.000142	CcSEcCtD
Trimethoprim—Nausea—Mitoxantrone—hematologic cancer	3.07e-05	0.000142	CcSEcCtD
Trimethoprim—TYMS—Clobetasol propionate—Prednisolone—hematologic cancer	3.07e-05	0.0078	CbGdCrCtD
Trimethoprim—Immune system disorder—Epirubicin—hematologic cancer	3.07e-05	0.000142	CcSEcCtD
Trimethoprim—Mediastinal disorder—Epirubicin—hematologic cancer	3.06e-05	0.000142	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.06e-05	0.000142	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.06e-05	0.000142	CcSEcCtD
Trimethoprim—TYMS—Diflorasone—Dexamethasone—hematologic cancer	3.06e-05	0.00776	CbGdCrCtD
Trimethoprim—TYMS—Diflorasone—Betamethasone—hematologic cancer	3.06e-05	0.00776	CbGdCrCtD
Trimethoprim—Pruritus—Etoposide—hematologic cancer	3.04e-05	0.000141	CcSEcCtD
Trimethoprim—Shock—Prednisone—hematologic cancer	3.03e-05	0.000141	CcSEcCtD
Trimethoprim—TYMS—Flunisolide—Prednisolone—hematologic cancer	3.03e-05	0.00769	CbGdCrCtD
Trimethoprim—Nervous system disorder—Prednisone—hematologic cancer	3.02e-05	0.00014	CcSEcCtD
Trimethoprim—TYMS—Triamcinolone—Prednisolone—hematologic cancer	3e-05	0.00762	CbGdCrCtD
Trimethoprim—Skin disorder—Prednisone—hematologic cancer	3e-05	0.000139	CcSEcCtD
Trimethoprim—Nausea—Gemcitabine—hematologic cancer	2.99e-05	0.000139	CcSEcCtD
Trimethoprim—Vomiting—Cisplatin—hematologic cancer	2.99e-05	0.000138	CcSEcCtD
Trimethoprim—TYMS—Diflorasone—Triamcinolone—hematologic cancer	2.99e-05	0.00758	CbGdCrCtD
Trimethoprim—Mental disorder—Epirubicin—hematologic cancer	2.97e-05	0.000138	CcSEcCtD
Trimethoprim—Erythema multiforme—Doxorubicin—hematologic cancer	2.97e-05	0.000138	CcSEcCtD
Trimethoprim—Rash—Cisplatin—hematologic cancer	2.96e-05	0.000137	CcSEcCtD
Trimethoprim—Dermatitis—Cisplatin—hematologic cancer	2.96e-05	0.000137	CcSEcCtD
Trimethoprim—Erythema—Epirubicin—hematologic cancer	2.96e-05	0.000137	CcSEcCtD
Trimethoprim—Malnutrition—Epirubicin—hematologic cancer	2.96e-05	0.000137	CcSEcCtD
Trimethoprim—Diarrhoea—Etoposide—hematologic cancer	2.94e-05	0.000136	CcSEcCtD
Trimethoprim—Anorexia—Prednisone—hematologic cancer	2.94e-05	0.000136	CcSEcCtD
Trimethoprim—Eye disorder—Doxorubicin—hematologic cancer	2.94e-05	0.000136	CcSEcCtD
Trimethoprim—Tinnitus—Doxorubicin—hematologic cancer	2.93e-05	0.000136	CcSEcCtD
Trimethoprim—Feeling abnormal—Betamethasone—hematologic cancer	2.92e-05	0.000135	CcSEcCtD
Trimethoprim—Feeling abnormal—Dexamethasone—hematologic cancer	2.92e-05	0.000135	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Betamethasone—hematologic cancer	2.9e-05	0.000134	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.9e-05	0.000134	CcSEcCtD
Trimethoprim—Hypersensitivity—Triamcinolone—hematologic cancer	2.88e-05	0.000133	CcSEcCtD
Trimethoprim—Dizziness—Etoposide—hematologic cancer	2.85e-05	0.000132	CcSEcCtD
Trimethoprim—Immune system disorder—Doxorubicin—hematologic cancer	2.84e-05	0.000131	CcSEcCtD
Trimethoprim—Vertigo—Methotrexate—hematologic cancer	2.84e-05	0.000131	CcSEcCtD
Trimethoprim—TYMS—Diflorasone—Prednisone—hematologic cancer	2.83e-05	0.00719	CbGdCrCtD
Trimethoprim—Mediastinal disorder—Doxorubicin—hematologic cancer	2.83e-05	0.000131	CcSEcCtD
Trimethoprim—Leukopenia—Methotrexate—hematologic cancer	2.83e-05	0.000131	CcSEcCtD
Trimethoprim—Urticaria—Betamethasone—hematologic cancer	2.81e-05	0.00013	CcSEcCtD
Trimethoprim—Urticaria—Dexamethasone—hematologic cancer	2.81e-05	0.00013	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.81e-05	0.00013	CcSEcCtD
Trimethoprim—Dizziness—Prednisolone—hematologic cancer	2.81e-05	0.00013	CcSEcCtD
Trimethoprim—Body temperature increased—Dexamethasone—hematologic cancer	2.8e-05	0.00013	CcSEcCtD
Trimethoprim—Body temperature increased—Betamethasone—hematologic cancer	2.8e-05	0.00013	CcSEcCtD
Trimethoprim—Abdominal pain—Betamethasone—hematologic cancer	2.8e-05	0.00013	CcSEcCtD
Trimethoprim—Abdominal pain—Dexamethasone—hematologic cancer	2.8e-05	0.00013	CcSEcCtD
Trimethoprim—Nausea—Cisplatin—hematologic cancer	2.79e-05	0.000129	CcSEcCtD
Trimethoprim—Insomnia—Prednisone—hematologic cancer	2.79e-05	0.000129	CcSEcCtD
Trimethoprim—TYMS—Diflorasone—Prednisolone—hematologic cancer	2.77e-05	0.00702	CbGdCrCtD
Trimethoprim—Pruritus—Triamcinolone—hematologic cancer	2.76e-05	0.000128	CcSEcCtD
Trimethoprim—Cough—Methotrexate—hematologic cancer	2.76e-05	0.000128	CcSEcCtD
Trimethoprim—Mental disorder—Doxorubicin—hematologic cancer	2.75e-05	0.000128	CcSEcCtD
Trimethoprim—Convulsion—Methotrexate—hematologic cancer	2.74e-05	0.000127	CcSEcCtD
Trimethoprim—Vomiting—Etoposide—hematologic cancer	2.74e-05	0.000127	CcSEcCtD
Trimethoprim—Malnutrition—Doxorubicin—hematologic cancer	2.73e-05	0.000127	CcSEcCtD
Trimethoprim—Erythema—Doxorubicin—hematologic cancer	2.73e-05	0.000127	CcSEcCtD
Trimethoprim—Agitation—Epirubicin—hematologic cancer	2.72e-05	0.000126	CcSEcCtD
Trimethoprim—Dyspepsia—Prednisone—hematologic cancer	2.71e-05	0.000126	CcSEcCtD
Trimethoprim—Rash—Etoposide—hematologic cancer	2.71e-05	0.000126	CcSEcCtD
Trimethoprim—Dermatitis—Etoposide—hematologic cancer	2.71e-05	0.000126	CcSEcCtD
Trimethoprim—Headache—Etoposide—hematologic cancer	2.7e-05	0.000125	CcSEcCtD
Trimethoprim—Myalgia—Methotrexate—hematologic cancer	2.69e-05	0.000125	CcSEcCtD
Trimethoprim—Arthralgia—Methotrexate—hematologic cancer	2.69e-05	0.000125	CcSEcCtD
Trimethoprim—Decreased appetite—Prednisone—hematologic cancer	2.68e-05	0.000124	CcSEcCtD
Trimethoprim—TYMS—Budesonide—Betamethasone—hematologic cancer	2.68e-05	0.0068	CbGdCrCtD
Trimethoprim—TYMS—Budesonide—Dexamethasone—hematologic cancer	2.68e-05	0.0068	CbGdCrCtD
Trimethoprim—Rash—Prednisolone—hematologic cancer	2.68e-05	0.000124	CcSEcCtD
Trimethoprim—Dermatitis—Prednisolone—hematologic cancer	2.67e-05	0.000124	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.67e-05	0.000124	CcSEcCtD
Trimethoprim—Headache—Prednisolone—hematologic cancer	2.66e-05	0.000123	CcSEcCtD
Trimethoprim—Vertigo—Epirubicin—hematologic cancer	2.66e-05	0.000123	CcSEcCtD
Trimethoprim—Syncope—Epirubicin—hematologic cancer	2.65e-05	0.000123	CcSEcCtD
Trimethoprim—Leukopenia—Epirubicin—hematologic cancer	2.65e-05	0.000123	CcSEcCtD
Trimethoprim—Constipation—Prednisone—hematologic cancer	2.64e-05	0.000122	CcSEcCtD
Trimethoprim—TYMS—Budesonide—Triamcinolone—hematologic cancer	2.62e-05	0.00664	CbGdCrCtD
Trimethoprim—Confusional state—Methotrexate—hematologic cancer	2.6e-05	0.00012	CcSEcCtD
Trimethoprim—Loss of consciousness—Epirubicin—hematologic cancer	2.6e-05	0.00012	CcSEcCtD
Trimethoprim—Dizziness—Triamcinolone—hematologic cancer	2.58e-05	0.00012	CcSEcCtD
Trimethoprim—Cough—Epirubicin—hematologic cancer	2.58e-05	0.00012	CcSEcCtD
Trimethoprim—Anaphylactic shock—Methotrexate—hematologic cancer	2.58e-05	0.000119	CcSEcCtD
Trimethoprim—Convulsion—Epirubicin—hematologic cancer	2.56e-05	0.000119	CcSEcCtD
Trimethoprim—Nausea—Etoposide—hematologic cancer	2.56e-05	0.000118	CcSEcCtD
Trimethoprim—Feeling abnormal—Prednisone—hematologic cancer	2.54e-05	0.000118	CcSEcCtD
Trimethoprim—Nervous system disorder—Methotrexate—hematologic cancer	2.53e-05	0.000117	CcSEcCtD
Trimethoprim—Thrombocytopenia—Methotrexate—hematologic cancer	2.52e-05	0.000117	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Prednisone—hematologic cancer	2.52e-05	0.000117	CcSEcCtD
Trimethoprim—Nausea—Prednisolone—hematologic cancer	2.52e-05	0.000117	CcSEcCtD
Trimethoprim—Arthralgia—Epirubicin—hematologic cancer	2.52e-05	0.000117	CcSEcCtD
Trimethoprim—Myalgia—Epirubicin—hematologic cancer	2.52e-05	0.000117	CcSEcCtD
Trimethoprim—Agitation—Doxorubicin—hematologic cancer	2.51e-05	0.000116	CcSEcCtD
Trimethoprim—Anxiety—Epirubicin—hematologic cancer	2.51e-05	0.000116	CcSEcCtD
Trimethoprim—Pruritus—Betamethasone—hematologic cancer	2.51e-05	0.000116	CcSEcCtD
Trimethoprim—Pruritus—Dexamethasone—hematologic cancer	2.51e-05	0.000116	CcSEcCtD
Trimethoprim—Skin disorder—Methotrexate—hematologic cancer	2.5e-05	0.000116	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.5e-05	0.000116	CcSEcCtD
Trimethoprim—TYMS—Budesonide—Prednisone—hematologic cancer	2.48e-05	0.0063	CbGdCrCtD
Trimethoprim—Vomiting—Triamcinolone—hematologic cancer	2.48e-05	0.000115	CcSEcCtD
Trimethoprim—Rash—Triamcinolone—hematologic cancer	2.46e-05	0.000114	CcSEcCtD
Trimethoprim—Dermatitis—Triamcinolone—hematologic cancer	2.46e-05	0.000114	CcSEcCtD
Trimethoprim—Vertigo—Doxorubicin—hematologic cancer	2.46e-05	0.000114	CcSEcCtD
Trimethoprim—Anorexia—Methotrexate—hematologic cancer	2.46e-05	0.000114	CcSEcCtD
Trimethoprim—Syncope—Doxorubicin—hematologic cancer	2.45e-05	0.000114	CcSEcCtD
Trimethoprim—Urticaria—Prednisone—hematologic cancer	2.45e-05	0.000114	CcSEcCtD
Trimethoprim—Leukopenia—Doxorubicin—hematologic cancer	2.45e-05	0.000113	CcSEcCtD
Trimethoprim—Headache—Triamcinolone—hematologic cancer	2.45e-05	0.000113	CcSEcCtD
Trimethoprim—Abdominal pain—Prednisone—hematologic cancer	2.44e-05	0.000113	CcSEcCtD
Trimethoprim—Body temperature increased—Prednisone—hematologic cancer	2.44e-05	0.000113	CcSEcCtD
Trimethoprim—Confusional state—Epirubicin—hematologic cancer	2.43e-05	0.000113	CcSEcCtD
Trimethoprim—TYMS—Budesonide—Prednisolone—hematologic cancer	2.42e-05	0.00615	CbGdCrCtD
Trimethoprim—Diarrhoea—Betamethasone—hematologic cancer	2.42e-05	0.000112	CcSEcCtD
Trimethoprim—Diarrhoea—Dexamethasone—hematologic cancer	2.42e-05	0.000112	CcSEcCtD
Trimethoprim—Anaphylactic shock—Epirubicin—hematologic cancer	2.41e-05	0.000112	CcSEcCtD
Trimethoprim—Loss of consciousness—Doxorubicin—hematologic cancer	2.4e-05	0.000111	CcSEcCtD
Trimethoprim—Cough—Doxorubicin—hematologic cancer	2.39e-05	0.000111	CcSEcCtD
Trimethoprim—TYMS—Danazol—Prednisone—hematologic cancer	2.38e-05	0.00604	CbGdCrCtD
Trimethoprim—Shock—Epirubicin—hematologic cancer	2.37e-05	0.00011	CcSEcCtD
Trimethoprim—Convulsion—Doxorubicin—hematologic cancer	2.37e-05	0.00011	CcSEcCtD
Trimethoprim—Nervous system disorder—Epirubicin—hematologic cancer	2.37e-05	0.00011	CcSEcCtD
Trimethoprim—Thrombocytopenia—Epirubicin—hematologic cancer	2.36e-05	0.000109	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.35e-05	0.000109	CcSEcCtD
Trimethoprim—Skin disorder—Epirubicin—hematologic cancer	2.34e-05	0.000109	CcSEcCtD
Trimethoprim—Dizziness—Betamethasone—hematologic cancer	2.34e-05	0.000109	CcSEcCtD
Trimethoprim—Dizziness—Dexamethasone—hematologic cancer	2.34e-05	0.000109	CcSEcCtD
Trimethoprim—Insomnia—Methotrexate—hematologic cancer	2.33e-05	0.000108	CcSEcCtD
Trimethoprim—Arthralgia—Doxorubicin—hematologic cancer	2.33e-05	0.000108	CcSEcCtD
Trimethoprim—Myalgia—Doxorubicin—hematologic cancer	2.33e-05	0.000108	CcSEcCtD
Trimethoprim—Anxiety—Doxorubicin—hematologic cancer	2.32e-05	0.000108	CcSEcCtD
Trimethoprim—Nausea—Triamcinolone—hematologic cancer	2.32e-05	0.000107	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.31e-05	0.000107	CcSEcCtD
Trimethoprim—Anorexia—Epirubicin—hematologic cancer	2.3e-05	0.000107	CcSEcCtD
Trimethoprim—Dyspnoea—Methotrexate—hematologic cancer	2.3e-05	0.000106	CcSEcCtD
Trimethoprim—Hypersensitivity—Prednisone—hematologic cancer	2.27e-05	0.000105	CcSEcCtD
Trimethoprim—Dyspepsia—Methotrexate—hematologic cancer	2.27e-05	0.000105	CcSEcCtD
Trimethoprim—Vomiting—Betamethasone—hematologic cancer	2.25e-05	0.000104	CcSEcCtD
Trimethoprim—Vomiting—Dexamethasone—hematologic cancer	2.25e-05	0.000104	CcSEcCtD
Trimethoprim—Confusional state—Doxorubicin—hematologic cancer	2.25e-05	0.000104	CcSEcCtD
Trimethoprim—Decreased appetite—Methotrexate—hematologic cancer	2.24e-05	0.000104	CcSEcCtD
Trimethoprim—Rash—Dexamethasone—hematologic cancer	2.23e-05	0.000103	CcSEcCtD
Trimethoprim—Rash—Betamethasone—hematologic cancer	2.23e-05	0.000103	CcSEcCtD
Trimethoprim—Anaphylactic shock—Doxorubicin—hematologic cancer	2.23e-05	0.000103	CcSEcCtD
Trimethoprim—Dermatitis—Betamethasone—hematologic cancer	2.23e-05	0.000103	CcSEcCtD
Trimethoprim—Dermatitis—Dexamethasone—hematologic cancer	2.23e-05	0.000103	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.23e-05	0.000103	CcSEcCtD
Trimethoprim—Headache—Betamethasone—hematologic cancer	2.22e-05	0.000103	CcSEcCtD
Trimethoprim—Headache—Dexamethasone—hematologic cancer	2.22e-05	0.000103	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.2e-05	0.000102	CcSEcCtD
Trimethoprim—Shock—Doxorubicin—hematologic cancer	2.2e-05	0.000102	CcSEcCtD
Trimethoprim—Nervous system disorder—Doxorubicin—hematologic cancer	2.19e-05	0.000101	CcSEcCtD
Trimethoprim—Thrombocytopenia—Doxorubicin—hematologic cancer	2.19e-05	0.000101	CcSEcCtD
Trimethoprim—Pruritus—Prednisone—hematologic cancer	2.18e-05	0.000101	CcSEcCtD
Trimethoprim—Insomnia—Epirubicin—hematologic cancer	2.18e-05	0.000101	CcSEcCtD
Trimethoprim—Skin disorder—Doxorubicin—hematologic cancer	2.17e-05	0.0001	CcSEcCtD
Trimethoprim—Dyspnoea—Epirubicin—hematologic cancer	2.15e-05	9.96e-05	CcSEcCtD
Trimethoprim—Anorexia—Doxorubicin—hematologic cancer	2.13e-05	9.86e-05	CcSEcCtD
Trimethoprim—Feeling abnormal—Methotrexate—hematologic cancer	2.12e-05	9.84e-05	CcSEcCtD
Trimethoprim—Dyspepsia—Epirubicin—hematologic cancer	2.12e-05	9.84e-05	CcSEcCtD
Trimethoprim—Diarrhoea—Prednisone—hematologic cancer	2.11e-05	9.78e-05	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Methotrexate—hematologic cancer	2.11e-05	9.77e-05	CcSEcCtD
Trimethoprim—Nausea—Betamethasone—hematologic cancer	2.1e-05	9.75e-05	CcSEcCtD
Trimethoprim—Nausea—Dexamethasone—hematologic cancer	2.1e-05	9.75e-05	CcSEcCtD
Trimethoprim—Decreased appetite—Epirubicin—hematologic cancer	2.1e-05	9.72e-05	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.08e-05	9.65e-05	CcSEcCtD
Trimethoprim—Constipation—Epirubicin—hematologic cancer	2.06e-05	9.56e-05	CcSEcCtD
Trimethoprim—Urticaria—Methotrexate—hematologic cancer	2.05e-05	9.49e-05	CcSEcCtD
Trimethoprim—Dizziness—Prednisone—hematologic cancer	2.04e-05	9.45e-05	CcSEcCtD
Trimethoprim—Body temperature increased—Methotrexate—hematologic cancer	2.04e-05	9.44e-05	CcSEcCtD
Trimethoprim—Abdominal pain—Methotrexate—hematologic cancer	2.04e-05	9.44e-05	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.03e-05	9.42e-05	CcSEcCtD
Trimethoprim—Insomnia—Doxorubicin—hematologic cancer	2.02e-05	9.35e-05	CcSEcCtD
Trimethoprim—Dyspnoea—Doxorubicin—hematologic cancer	1.99e-05	9.22e-05	CcSEcCtD
Trimethoprim—Feeling abnormal—Epirubicin—hematologic cancer	1.99e-05	9.21e-05	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Epirubicin—hematologic cancer	1.97e-05	9.14e-05	CcSEcCtD
Trimethoprim—Dyspepsia—Doxorubicin—hematologic cancer	1.96e-05	9.1e-05	CcSEcCtD
Trimethoprim—Vomiting—Prednisone—hematologic cancer	1.96e-05	9.09e-05	CcSEcCtD
Trimethoprim—Rash—Prednisone—hematologic cancer	1.94e-05	9.01e-05	CcSEcCtD
Trimethoprim—Dermatitis—Prednisone—hematologic cancer	1.94e-05	9e-05	CcSEcCtD
Trimethoprim—Decreased appetite—Doxorubicin—hematologic cancer	1.94e-05	8.99e-05	CcSEcCtD
Trimethoprim—Headache—Prednisone—hematologic cancer	1.93e-05	8.95e-05	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.93e-05	8.93e-05	CcSEcCtD
Trimethoprim—Urticaria—Epirubicin—hematologic cancer	1.92e-05	8.88e-05	CcSEcCtD
Trimethoprim—Constipation—Doxorubicin—hematologic cancer	1.91e-05	8.84e-05	CcSEcCtD
Trimethoprim—Abdominal pain—Epirubicin—hematologic cancer	1.91e-05	8.84e-05	CcSEcCtD
Trimethoprim—Body temperature increased—Epirubicin—hematologic cancer	1.91e-05	8.84e-05	CcSEcCtD
Trimethoprim—Hypersensitivity—Methotrexate—hematologic cancer	1.9e-05	8.8e-05	CcSEcCtD
Trimethoprim—Feeling abnormal—Doxorubicin—hematologic cancer	1.84e-05	8.52e-05	CcSEcCtD
Trimethoprim—Nausea—Prednisone—hematologic cancer	1.83e-05	8.49e-05	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.83e-05	8.46e-05	CcSEcCtD
Trimethoprim—Pruritus—Methotrexate—hematologic cancer	1.82e-05	8.45e-05	CcSEcCtD
Trimethoprim—Hypersensitivity—Epirubicin—hematologic cancer	1.78e-05	8.23e-05	CcSEcCtD
Trimethoprim—Urticaria—Doxorubicin—hematologic cancer	1.77e-05	8.22e-05	CcSEcCtD
Trimethoprim—Abdominal pain—Doxorubicin—hematologic cancer	1.76e-05	8.18e-05	CcSEcCtD
Trimethoprim—Body temperature increased—Doxorubicin—hematologic cancer	1.76e-05	8.18e-05	CcSEcCtD
Trimethoprim—Diarrhoea—Methotrexate—hematologic cancer	1.76e-05	8.17e-05	CcSEcCtD
Trimethoprim—Pruritus—Epirubicin—hematologic cancer	1.71e-05	7.91e-05	CcSEcCtD
Trimethoprim—Dizziness—Methotrexate—hematologic cancer	1.7e-05	7.9e-05	CcSEcCtD
Trimethoprim—Diarrhoea—Epirubicin—hematologic cancer	1.65e-05	7.65e-05	CcSEcCtD
Trimethoprim—Hypersensitivity—Doxorubicin—hematologic cancer	1.64e-05	7.62e-05	CcSEcCtD
Trimethoprim—Vomiting—Methotrexate—hematologic cancer	1.64e-05	7.59e-05	CcSEcCtD
Trimethoprim—Rash—Methotrexate—hematologic cancer	1.63e-05	7.53e-05	CcSEcCtD
Trimethoprim—Dermatitis—Methotrexate—hematologic cancer	1.62e-05	7.52e-05	CcSEcCtD
Trimethoprim—Headache—Methotrexate—hematologic cancer	1.61e-05	7.48e-05	CcSEcCtD
Trimethoprim—Dizziness—Epirubicin—hematologic cancer	1.6e-05	7.39e-05	CcSEcCtD
Trimethoprim—Pruritus—Doxorubicin—hematologic cancer	1.58e-05	7.32e-05	CcSEcCtD
Trimethoprim—Vomiting—Epirubicin—hematologic cancer	1.53e-05	7.11e-05	CcSEcCtD
Trimethoprim—Nausea—Methotrexate—hematologic cancer	1.53e-05	7.09e-05	CcSEcCtD
Trimethoprim—Diarrhoea—Doxorubicin—hematologic cancer	1.53e-05	7.08e-05	CcSEcCtD
Trimethoprim—Rash—Epirubicin—hematologic cancer	1.52e-05	7.05e-05	CcSEcCtD
Trimethoprim—Dermatitis—Epirubicin—hematologic cancer	1.52e-05	7.04e-05	CcSEcCtD
Trimethoprim—Headache—Epirubicin—hematologic cancer	1.51e-05	7e-05	CcSEcCtD
Trimethoprim—Dizziness—Doxorubicin—hematologic cancer	1.48e-05	6.84e-05	CcSEcCtD
Trimethoprim—Nausea—Epirubicin—hematologic cancer	1.43e-05	6.64e-05	CcSEcCtD
Trimethoprim—Vomiting—Doxorubicin—hematologic cancer	1.42e-05	6.58e-05	CcSEcCtD
Trimethoprim—Rash—Doxorubicin—hematologic cancer	1.41e-05	6.52e-05	CcSEcCtD
Trimethoprim—Dermatitis—Doxorubicin—hematologic cancer	1.41e-05	6.51e-05	CcSEcCtD
Trimethoprim—Headache—Doxorubicin—hematologic cancer	1.4e-05	6.48e-05	CcSEcCtD
Trimethoprim—Nausea—Doxorubicin—hematologic cancer	1.33e-05	6.14e-05	CcSEcCtD
Trimethoprim—DHFR—Disease—PIK3CB—hematologic cancer	9.88e-06	0.000119	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MTOR—hematologic cancer	9.88e-06	0.000119	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	9.87e-06	0.000119	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CD4—hematologic cancer	9.86e-06	0.000119	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—AGRN—hematologic cancer	9.84e-06	0.000118	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ACP5—hematologic cancer	9.79e-06	0.000118	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CA9—hematologic cancer	9.79e-06	0.000118	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—NCOR2—hematologic cancer	9.66e-06	0.000116	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	9.6e-06	0.000116	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PIK3CD—hematologic cancer	9.49e-06	0.000114	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PIK3CG—hematologic cancer	9.42e-06	0.000113	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—B3GAT1—hematologic cancer	9.4e-06	0.000113	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—DCK—hematologic cancer	9.4e-06	0.000113	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ASNS—hematologic cancer	9.4e-06	0.000113	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—ALB—hematologic cancer	9.37e-06	0.000113	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—FHL2—hematologic cancer	9.37e-06	0.000113	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	9.35e-06	0.000113	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—HMMR—hematologic cancer	9.33e-06	0.000112	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—IDH2—hematologic cancer	9.33e-06	0.000112	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CDKN1B—hematologic cancer	9.27e-06	0.000112	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—IDH1—hematologic cancer	9.2e-06	0.000111	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—AGRN—hematologic cancer	9.19e-06	0.000111	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GSTO1—hematologic cancer	9.1e-06	0.000109	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ABCC3—hematologic cancer	9.1e-06	0.000109	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—TXN—hematologic cancer	9.1e-06	0.000109	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PIK3R1—hematologic cancer	8.97e-06	0.000108	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—HDC—hematologic cancer	8.92e-06	0.000107	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—SPHK1—hematologic cancer	8.91e-06	0.000107	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	8.85e-06	0.000106	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ARNTL—hematologic cancer	8.77e-06	0.000105	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—CREBBP—hematologic cancer	8.74e-06	0.000105	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—IDH2—hematologic cancer	8.71e-06	0.000105	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—HMMR—hematologic cancer	8.71e-06	0.000105	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	8.6e-06	0.000104	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	8.58e-06	0.000103	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CDKN1A—hematologic cancer	8.56e-06	0.000103	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—UGT1A1—hematologic cancer	8.56e-06	0.000103	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PTEN—hematologic cancer	8.54e-06	0.000103	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CA9—hematologic cancer	8.53e-06	0.000103	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ACP5—hematologic cancer	8.53e-06	0.000103	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—NCOR2—hematologic cancer	8.42e-06	0.000101	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—SLC22A1—hematologic cancer	8.32e-06	0.0001	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CRABP1—hematologic cancer	8.32e-06	0.0001	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PIK3CD—hematologic cancer	8.28e-06	9.97e-05	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PIK3CB—hematologic cancer	8.28e-06	9.96e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	8.21e-06	9.88e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ARNTL—hematologic cancer	8.19e-06	9.85e-05	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—ALB—hematologic cancer	8.18e-06	9.84e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CDA—hematologic cancer	8.15e-06	9.81e-05	CbGpPWpGaD
Trimethoprim—DHFR—Disease—EP300—hematologic cancer	8.14e-06	9.8e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ALOX5—hematologic cancer	8.11e-06	9.76e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—IDH1—hematologic cancer	8.02e-06	9.65e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	8.01e-06	9.64e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ACP5—hematologic cancer	7.97e-06	9.59e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CA9—hematologic cancer	7.97e-06	9.59e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	7.95e-06	9.56e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GSTO1—hematologic cancer	7.93e-06	9.54e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—TXN—hematologic cancer	7.93e-06	9.54e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ABCC3—hematologic cancer	7.93e-06	9.54e-05	CbGpPWpGaD
Trimethoprim—DHFR—Disease—SRC—hematologic cancer	7.92e-06	9.53e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—NCOR2—hematologic cancer	7.86e-06	9.46e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—NUP98—hematologic cancer	7.86e-06	9.45e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PC—hematologic cancer	7.85e-06	9.44e-05	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PIK3R1—hematologic cancer	7.82e-06	9.41e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—SPHK1—hematologic cancer	7.76e-06	9.33e-05	CbGpPWpGaD
Trimethoprim—DHFR—Disease—STAT3—hematologic cancer	7.64e-06	9.19e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ADCY7—hematologic cancer	7.63e-06	9.18e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—NCOA3—hematologic cancer	7.63e-06	9.18e-05	CbGpPWpGaD
Trimethoprim—DHFR—Disease—NRAS—hematologic cancer	7.62e-06	9.16e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GBA—hematologic cancer	7.58e-06	9.12e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—SLC35B2—hematologic cancer	7.58e-06	9.12e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—NUP214—hematologic cancer	7.57e-06	9.11e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.49e-06	9.02e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—IDH1—hematologic cancer	7.49e-06	9.01e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—UGT1A1—hematologic cancer	7.45e-06	8.97e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ABCG2—hematologic cancer	7.42e-06	8.93e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—MTR—hematologic cancer	7.42e-06	8.93e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ABCC3—hematologic cancer	7.41e-06	8.91e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—TXN—hematologic cancer	7.41e-06	8.91e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GSTO1—hematologic cancer	7.41e-06	8.91e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	7.3e-06	8.79e-05	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MAPK3—hematologic cancer	7.3e-06	8.78e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ENO2—hematologic cancer	7.28e-06	8.75e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—SLC22A1—hematologic cancer	7.25e-06	8.72e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CRABP1—hematologic cancer	7.25e-06	8.72e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—SPHK1—hematologic cancer	7.25e-06	8.72e-05	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PIK3CB—hematologic cancer	7.22e-06	8.69e-05	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PTEN—hematologic cancer	7.15e-06	8.6e-05	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MYC—hematologic cancer	7.1e-06	8.54e-05	CbGpPWpGaD
Trimethoprim—DHFR—Disease—TGFB1—hematologic cancer	7.08e-06	8.52e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ALOX5—hematologic cancer	7.07e-06	8.5e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	7.07e-06	8.5e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GSTT1—hematologic cancer	7.06e-06	8.49e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—UGT1A1—hematologic cancer	6.96e-06	8.38e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.95e-06	8.36e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—MTAP—hematologic cancer	6.93e-06	8.34e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—SDC1—hematologic cancer	6.9e-06	8.3e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—NUP98—hematologic cancer	6.84e-06	8.23e-05	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—EP300—hematologic cancer	6.82e-06	8.2e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—SLC22A1—hematologic cancer	6.77e-06	8.15e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CRABP1—hematologic cancer	6.77e-06	8.15e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ADCY7—hematologic cancer	6.64e-06	7.99e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—NCOA3—hematologic cancer	6.64e-06	7.99e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ALOX5—hematologic cancer	6.6e-06	7.94e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—NUP214—hematologic cancer	6.6e-06	7.94e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.59e-06	7.93e-05	CbGpPWpGaD
Trimethoprim—DHFR—Disease—KRAS—hematologic cancer	6.56e-06	7.89e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.5e-06	7.82e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—MTR—hematologic cancer	6.46e-06	7.78e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ABCG2—hematologic cancer	6.46e-06	7.78e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—NUP98—hematologic cancer	6.39e-06	7.69e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ENO2—hematologic cancer	6.34e-06	7.63e-05	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PTEN—hematologic cancer	6.24e-06	7.51e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.22e-06	7.48e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ADCY7—hematologic cancer	6.21e-06	7.47e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—NCOA3—hematologic cancer	6.21e-06	7.47e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—FHL2—hematologic cancer	6.18e-06	7.43e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—NUP214—hematologic cancer	6.16e-06	7.41e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GSTT1—hematologic cancer	6.15e-06	7.4e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.1e-06	7.34e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—AGRN—hematologic cancer	6.06e-06	7.29e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—MTR—hematologic cancer	6.04e-06	7.26e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ABCG2—hematologic cancer	6.04e-06	7.26e-05	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PIK3CA—hematologic cancer	6.02e-06	7.25e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—SDC1—hematologic cancer	6.01e-06	7.23e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	5.97e-06	7.18e-05	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—EP300—hematologic cancer	5.95e-06	7.16e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ENO2—hematologic cancer	5.92e-06	7.12e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—NQO1—hematologic cancer	5.86e-06	7.06e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CD44—hematologic cancer	5.86e-06	7.06e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.76e-06	6.92e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—IDH2—hematologic cancer	5.75e-06	6.91e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—HMMR—hematologic cancer	5.75e-06	6.91e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GSTT1—hematologic cancer	5.74e-06	6.91e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.74e-06	6.91e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.66e-06	6.8e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—SDC1—hematologic cancer	5.61e-06	6.75e-05	CbGpPWpGaD
Trimethoprim—DHFR—Disease—HRAS—hematologic cancer	5.57e-06	6.7e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYCS—hematologic cancer	5.55e-06	6.68e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	5.51e-06	6.63e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ARNTL—hematologic cancer	5.4e-06	6.5e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	5.39e-06	6.48e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.36e-06	6.45e-05	CbGpPWpGaD
Trimethoprim—DHFR—Disease—IL6—hematologic cancer	5.33e-06	6.42e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.29e-06	6.37e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ACP5—hematologic cancer	5.25e-06	6.32e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CA9—hematologic cancer	5.25e-06	6.32e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—NCOR2—hematologic cancer	5.19e-06	6.24e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CD44—hematologic cancer	5.11e-06	6.15e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—NQO1—hematologic cancer	5.11e-06	6.15e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.06e-06	6.09e-05	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PIK3CA—hematologic cancer	5.04e-06	6.07e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.96e-06	5.97e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—IDH1—hematologic cancer	4.94e-06	5.94e-05	CbGpPWpGaD
Trimethoprim—DHFR—Disease—AKT1—hematologic cancer	4.92e-06	5.92e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GSTP1—hematologic cancer	4.89e-06	5.88e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—TXN—hematologic cancer	4.89e-06	5.88e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GSTO1—hematologic cancer	4.89e-06	5.88e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ABCC3—hematologic cancer	4.89e-06	5.88e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYCS—hematologic cancer	4.83e-06	5.82e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—HSP90AA1—hematologic cancer	4.8e-06	5.78e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—SPHK1—hematologic cancer	4.78e-06	5.75e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CD44—hematologic cancer	4.77e-06	5.74e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—NQO1—hematologic cancer	4.77e-06	5.74e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.73e-06	5.69e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.67e-06	5.62e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ABCB1—hematologic cancer	4.63e-06	5.57e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4.59e-06	5.53e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYCS—hematologic cancer	4.52e-06	5.43e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GSTM1—hematologic cancer	4.5e-06	5.41e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—NCOR1—hematologic cancer	4.5e-06	5.41e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	4.49e-06	5.4e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CRABP1—hematologic cancer	4.47e-06	5.38e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—SLC22A1—hematologic cancer	4.47e-06	5.38e-05	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PIK3CA—hematologic cancer	4.4e-06	5.3e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ALOX5—hematologic cancer	4.35e-06	5.24e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GSTP1—hematologic cancer	4.26e-06	5.13e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—NUP98—hematologic cancer	4.22e-06	5.07e-05	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—AKT1—hematologic cancer	4.12e-06	4.96e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ADCY7—hematologic cancer	4.09e-06	4.92e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—NCOA3—hematologic cancer	4.09e-06	4.92e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—NUP214—hematologic cancer	4.06e-06	4.89e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.04e-06	4.86e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—MTR—hematologic cancer	3.98e-06	4.79e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.98e-06	4.79e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GSTP1—hematologic cancer	3.98e-06	4.79e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—MTHFR—hematologic cancer	3.97e-06	4.78e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—NCOR1—hematologic cancer	3.92e-06	4.71e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GSTM1—hematologic cancer	3.92e-06	4.71e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ENO2—hematologic cancer	3.91e-06	4.7e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.85e-06	4.63e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.79e-06	4.56e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ABCB1—hematologic cancer	3.77e-06	4.53e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—SDC1—hematologic cancer	3.7e-06	4.45e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—NCOR1—hematologic cancer	3.66e-06	4.4e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GSTM1—hematologic cancer	3.66e-06	4.4e-05	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—AKT1—hematologic cancer	3.6e-06	4.33e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.5e-06	4.21e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—MTHFR—hematologic cancer	3.46e-06	4.16e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3CG—hematologic cancer	3.34e-06	4.02e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—MTHFR—hematologic cancer	3.23e-06	3.89e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CD44—hematologic cancer	3.15e-06	3.79e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—NQO1—hematologic cancer	3.15e-06	3.79e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CREBBP—hematologic cancer	3.09e-06	3.72e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYCS—hematologic cancer	2.98e-06	3.58e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.96e-06	3.56e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3CD—hematologic cancer	2.93e-06	3.53e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3CG—hematologic cancer	2.91e-06	3.5e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ALB—hematologic cancer	2.9e-06	3.48e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.85e-06	3.43e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3R1—hematologic cancer	2.77e-06	3.33e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.72e-06	3.27e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CREBBP—hematologic cancer	2.7e-06	3.24e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.63e-06	3.16e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3CB—hematologic cancer	2.56e-06	3.08e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3CD—hematologic cancer	2.56e-06	3.08e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ALB—hematologic cancer	2.52e-06	3.04e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.52e-06	3.03e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.49e-06	2.99e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3R1—hematologic cancer	2.41e-06	2.9e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.41e-06	2.9e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.41e-06	2.9e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.39e-06	2.87e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ALB—hematologic cancer	2.36e-06	2.84e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3R1—hematologic cancer	2.26e-06	2.71e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3CB—hematologic cancer	2.23e-06	2.68e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PTEN—hematologic cancer	2.21e-06	2.66e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.13e-06	2.57e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—EP300—hematologic cancer	2.11e-06	2.54e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3CB—hematologic cancer	2.08e-06	2.5e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PTEN—hematologic cancer	1.93e-06	2.32e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—EP300—hematologic cancer	1.84e-06	2.21e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PTEN—hematologic cancer	1.8e-06	2.16e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.79e-06	2.16e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—EP300—hematologic cancer	1.72e-06	2.06e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.66e-06	2e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.57e-06	1.89e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.56e-06	1.88e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ALB—hematologic cancer	1.55e-06	1.87e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.49e-06	1.79e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.37e-06	1.65e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.36e-06	1.63e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—AKT1—hematologic cancer	1.27e-06	1.53e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.27e-06	1.53e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PTEN—hematologic cancer	1.19e-06	1.43e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—EP300—hematologic cancer	1.13e-06	1.36e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—AKT1—hematologic cancer	1.11e-06	1.33e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—AKT1—hematologic cancer	1.04e-06	1.25e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3CA—hematologic cancer	8.37e-07	1.01e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—AKT1—hematologic cancer	6.84e-07	8.22e-06	CbGpPWpGaD
